GOSS – Gossamer Bio Inc.
GOSS — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
19.66
Margin Of Safety %
Put/Call OI Ratio
0.15
EPS Next Q Diff
0.08
EPS Last/This Y
0.26
EPS This/Next Y
0.3
Price
0.33
Target Price
3.69
Analyst Recom
2.56
Performance Q
-87.97
Upside
-8,054.5%
Beta
2.22
Ticker: GOSS
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | GOSS | 0.5554 | 0.52 | 0.54 | 406060 |
| 2026-03-10 | GOSS | 0.5128 | 0.52 | 0.75 | 405373 |
| 2026-03-11 | GOSS | 0.4901 | 0.52 | 0.27 | 405169 |
| 2026-03-12 | GOSS | 0.4699 | 0.52 | 5.82 | 405336 |
| 2026-03-13 | GOSS | 0.46 | 0.52 | 5.82 | 405336 |
| 2026-03-17 | GOSS | 0.472 | 0.51 | 0.38 | 403963 |
| 2026-03-18 | GOSS | 0.4341 | 0.51 | 0.32 | 404266 |
| 2026-03-19 | GOSS | 0.4377 | 0.51 | 28.93 | 403787 |
| 2026-03-20 | GOSS | 0.4224 | 0.34 | 2.85 | 359144 |
| 2026-03-23 | GOSS | 0.3701 | 0.16 | 1.64 | 78783 |
| 2026-03-24 | GOSS | 0.3449 | 0.16 | 0.33 | 78876 |
| 2026-03-25 | GOSS | 0.3829 | 0.15 | 0.99 | 79868 |
| 2026-03-26 | GOSS | 0.3828 | 0.15 | 0.97 | 79799 |
| 2026-03-27 | GOSS | 0.3459 | 0.15 | 0.22 | 80062 |
| 2026-03-30 | GOSS | 0.324 | 0.15 | 0.17 | 80004 |
| 2026-03-31 | GOSS | 0.3308 | 0.15 | 0.28 | 80012 |
| 2026-04-01 | GOSS | 0.3634 | 0.15 | 0.20 | 80275 |
| 2026-04-02 | GOSS | 0.3636 | 0.15 | 3.17 | 80523 |
| 2026-04-06 | GOSS | 0.3435 | 0.15 | 0.87 | 80580 |
| 2026-04-07 | GOSS | 0.3258 | 0.15 | 1.86 | 81074 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | GOSS | 0.56 | -35.9 | 141.5 | -0.72 |
| 2026-03-10 | GOSS | 0.51 | -35.9 | 141.9 | -0.72 |
| 2026-03-11 | GOSS | 0.49 | -35.9 | 142.1 | -0.72 |
| 2026-03-12 | GOSS | 0.47 | -35.9 | 142.3 | -0.72 |
| 2026-03-13 | GOSS | 0.44 | -30.4 | 142.6 | -0.72 |
| 2026-03-17 | GOSS | 0.47 | -30.4 | 142.3 | -0.72 |
| 2026-03-18 | GOSS | 0.43 | -30.4 | 142.6 | -0.72 |
| 2026-03-19 | GOSS | 0.44 | -30.4 | 142.6 | -0.72 |
| 2026-03-20 | GOSS | 0.42 | -18.7 | 142.8 | -0.58 |
| 2026-03-23 | GOSS | 0.37 | -18.7 | 141.4 | -0.58 |
| 2026-03-24 | GOSS | 0.34 | -18.7 | 154.8 | -0.58 |
| 2026-03-25 | GOSS | 0.38 | -18.7 | 154.5 | -0.58 |
| 2026-03-26 | GOSS | 0.38 | -18.7 | 154.5 | -0.58 |
| 2026-03-27 | GOSS | 0.35 | -18.7 | 154.7 | -0.58 |
| 2026-03-30 | GOSS | 0.32 | -6.2 | 154.9 | -0.49 |
| 2026-03-31 | GOSS | 0.33 | -6.2 | 154.8 | -0.49 |
| 2026-04-01 | GOSS | 0.36 | -6.2 | 154.6 | -0.49 |
| 2026-04-02 | GOSS | 0.37 | -6.2 | 154.6 | -0.49 |
| 2026-04-06 | GOSS | 0.34 | -6.2 | 154.8 | -0.49 |
| 2026-04-07 | GOSS | 0.33 | -6.2 | 154.7 | -0.49 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | GOSS | 0.00 | -3.05 | 16.93 |
| 2026-03-10 | GOSS | 0.00 | -3.05 | 16.93 |
| 2026-03-11 | GOSS | 0.00 | -3.05 | 18.90 |
| 2026-03-12 | GOSS | 0.00 | -3.05 | 18.90 |
| 2026-03-13 | GOSS | 0.00 | -3.05 | 18.90 |
| 2026-03-17 | GOSS | 0.00 | -1.40 | 18.90 |
| 2026-03-18 | GOSS | 0.00 | -1.40 | 18.90 |
| 2026-03-19 | GOSS | 0.00 | -1.40 | 18.90 |
| 2026-03-20 | GOSS | 0.00 | -1.40 | 18.64 |
| 2026-03-23 | GOSS | 0.00 | -1.37 | 18.64 |
| 2026-03-24 | GOSS | 0.00 | -1.37 | 18.64 |
| 2026-03-25 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-03-26 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-03-27 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-03-30 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-03-31 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-04-01 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-04-02 | GOSS | 0.00 | -1.37 | 19.66 |
| 2026-04-06 | GOSS | 0.00 | -2.68 | 19.66 |
| 2026-04-07 | GOSS | 0.00 | -2.68 | 19.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.21
Avg. EPS Est. Current Quarter
-0.17
Avg. EPS Est. Next Quarter
-0.13
Insider Transactions
Institutional Transactions
-2.68
Beta
2.22
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
3
Fair Value
Quality Score
8
Growth Score
24
Sentiment Score
26
Actual DrawDown %
97.9
Max Drawdown 5-Year %
-97.8
Target Price
3.69
P/E
Forward P/E
PEG
P/S
1.6
P/B
P/Free Cash Flow
EPS
-0.75
Average EPS Est. Cur. Y
-0.49
EPS Next Y. (Est.)
-0.19
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-351.49
Relative Volume
0.51
Return on Equity vs Sector %
111.3
Return on Equity vs Industry %
127.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.09
EBIT Estimation
154.7
◆
GOSS
Healthcare
$0.33
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
8/20
Pullback
13/25
Volume
11/15
Valuation
12/20
TP/AR
0/10
Options
6/10
RSI
26.9
Range 1M
0.8%
Sup Dist
1%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
3/25
Growth
15/30
Estimates
0/20
Inst/Vol
0/15
Options
7/10
EPS Yr
38.2%
EPS NY
68.6%
52W%
0.1%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+1018.2% upside
Quality
7/30
Valuation
16/30
Growth
14/25
Stability
7/10
LT Trend
4/5
Upside
+1018.2%
Quality
8
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 161
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
GOSS
Latest News
—
Caricamento notizie per GOSS…
stock quote shares GOSS – Gossamer Bio Inc. Stock Price stock today
news today GOSS – Gossamer Bio Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GOSS – Gossamer Bio Inc. yahoo finance google finance
stock history GOSS – Gossamer Bio Inc. invest stock market
stock prices GOSS premarket after hours
ticker GOSS fair value insiders trading